[1]陈茜,刘伟,姜华,等.参苓白术散联合氨茶碱片治疗慢性阻塞性肺疾病的临床疗效[J].西部中医药,2020,33(06):95-97.[doi:10.12174/j.issn.1004-6852.2020.06.25]
 CHEN Xi,LIU Wei,JIANG Hua,et al.A Study on Clinical Effects of Shenling Baizhu Powder Combined with Aminophylline Tablets in Treating COPD[J].Western Journal of Traditional Chinese Medicine,2020,33(06):95-97.[doi:10.12174/j.issn.1004-6852.2020.06.25]
点击复制

参苓白术散联合氨茶碱片治疗慢性阻塞性肺疾病的临床疗效
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年06期
页码:
95-97
栏目:
出版日期:
2020-06-15

文章信息/Info

Title:
A Study on Clinical Effects of Shenling Baizhu Powder Combined with Aminophylline Tablets in Treating COPD
文章编号:
1004-6852(2020)06-0095-03
作者:
陈茜刘伟姜华李亚
1 镇安县医院,陕西 镇安 711500; 2 中国人民解放军第四军医大学; 3 西安市高陵区医院
Author(s):
CHEN Xi1, LIU Wei2, JIANG Hua2, LI Ya3△
1 Zhen′an County Hospital, Zheng′an 711500, China; 2 The Fourth Military Medical University; 3 Gaoling District Hospital
关键词:
阻塞性肺疾病慢性参苓白术散氨茶碱片临床疗效
Keywords:
obstructive pulmonary disease chronic Shenling Baizhu powder aminophylline tabletsclinical effects
分类号:
R256.1
DOI:
10.12174/j.issn.1004-6852.2020.06.25
文献标志码:
B
摘要:
目的:观察参苓白术散联合氨茶碱片治疗慢性阻塞性肺疾病的临床疗效。方法:将72例慢性阻塞性肺疾病患者随机分为两组,每组36例。给予两组吸氧、平喘、化痰、止咳和抗感染治疗。对照组口服氨茶碱片,0.1 g/次,每日3次。观察组在对照组基础上服用参苓白术散,每日1剂,水煎分服。两组均治疗3个月。比较两组患者肺功能、营养情况、住院时间及病死率。结果:总有效率观察组为91.67%(33/36),对照组为77.78%(28/36),两组比较差异有统计学意义(P<0.05)。治疗后两组体质指数及白蛋白水平均明显升高(P<0.05),且观察组升高更为明显(P<0.05)。观察组的住院时间及病死率均明显低于对照组(P<0.05)。治疗后,两组每分钟最大通气量(maximum ventilatory volume,MVV)、6 min步行距离和用力呼气量占用力肺活量比值(FEV1/FVC)均明显升高(P<0.05),且观察组更为明显(P<0.05)。结论:参苓白术散联合氨茶碱片对于慢性阻塞性肺疾病患者具有满意的治疗效果,可以有效改善患者机体营养、肺功能及运动量。
Abstract:
Objective: To explore clinical effects of Shenling Baizhu powder and aminophylline tablets in the treatment of the patients with chronic obstructive pulmonary disease (COPD). Methods: All 72 patients were randomized into two groups, 36 cases each group. Both groups accepted the therapy including oxygen inhalation, relieving asthma, reducing phlegm, stopping cough and fighting against infection, the control group took aminophylline tablets, 0.1g each time, three times each day. The observation group were given Shenling Baizhu powder simultaneously, one dose each day, water decocted. Both groups were treated for three months. To compare pulmonary function, nutritional conditions, hospitalization time and mortality between both groups. Results: Total effective rate of the observation group was 91.67% (33/36), higher than 77.78% (28/36) of the control group, and the difference had statistical meaning (P<0.05). After treating, body mass index and albumin level of both groups rose notably (P<0.05), and the increase of the observation group was more notable (P<0.05). The observation group was lower than the control group in hospitalization time and mortality notably (P<0.05). After treating, MVV and six minutes walking distances and FEV1/FVC of both groups rose notably (P<0.05), the rise of the observation group was more notable (P<0.05). Conclusion: Shenling Baizhu powder and aminophylline tablets own satisfactory therapeutic effects in the treatment of COPD, it could effectively improve body nutrition, pulmonary function and the amount of exercise.

相似文献/References:

[1]崔毅.益气活血汤治疗慢性盆腔炎64例临床观察[J].西部中医药,2012,25(12):75.
 CUI Yi.Clinical Observation on YiQi HuoXueTang and Activating Blood Decoction in Treating 64 Cases of Chronic Pelvic Inflammatory Disease[J].Western Journal of Traditional Chinese Medicine,2012,25(06):75.
[2]樊斗霜.枳实消痞丸(汤)合丹参饮加减治疗慢性萎缩性胃炎32例[J].西部中医药,2013,26(02):72.
 FAN Doushuang.Modified ZhiShi XiaoPiWan(Prescription) and DanShenYin in Treating 32 Cases of Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):72.
[3]尤海鹰.制萎煎治疗脾胃虚弱型慢性萎缩性胃炎40例[J].西部中医药,2013,26(03):84.
 YOU Haiying.ZhiWeiJian in Treating 40 Cases of Chronic Atrophic Gastritis of Spleen-stomach Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(06):84.
[4]张建平,刘洁,赵志亮.针灸治疗慢性前列腺炎25例疗效观察[J].西部中医药,2013,26(03):111.
 ZHANG Jianping,LIU Jie,ZHAO Zhiliang.Observation on Acupuncture in Treating 25 Cases of Chronic Prostatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):111.
[5]魏国俊,郑恒恒,指导:燕中.损伤胶囊与正骨水治疗慢性软组织损伤疗效比较[J].西部中医药,2013,26(11):8.
 WEI Guojun,ZHENG Hengheng,Director: YAN Zhong.The Difference in Clinical Effects between SunShang Capsule and Bonesetting Liquid in Treating Chronic Soft Tissue Injury[J].Western Journal of Traditional Chinese Medicine,2013,26(06):8.
[6]朱建坤,温晓辉,梁玉杰△.敦煌葆元膏对下丘脑-垂体-肾上腺轴作用的实验研究*[J].西部中医药,2013,26(11):13.
 ZHU Jiankun,WEN Xiaohui,LIANG Yujie.Experimental Study on the Effects of DunHuang BaoYuan Ointment on Hypothalamic-pituitary-adrenal Axis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):13.
[7]孙国荣,景克荣,权亚喜.生脉注射液对慢性心衰患者心功能及其心率变异性的影响[J].西部中医药,2013,26(04):68.
 SUN Guorong,JING Kerong,QUAN Yaxi.The Influence of ShengMai Injection on Heart Function and Heart Rate Variability of Patients with Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2013,26(06):68.
[8]俄静,夏小军,杨楠.益气温阳法治疗慢性血小板减少性紫癜经验举隅[J].西部中医药,2013,26(06):58.
 E Jing,XIA Xiaojun,YANG Nan.Invigorating Qi and Yang Method in Treating Chronic Thrombocytopenic Purpura[J].Western Journal of Traditional Chinese Medicine,2013,26(06):58.
[9]马继利.中西药物联用治疗慢性萎缩性胃炎58例[J].西部中医药,2013,26(06):91.
 MA Jili.Treatment for 58 Cases of Chronic Atrophic Gastritis with Integrative Medicines[J].Western Journal of Traditional Chinese Medicine,2013,26(06):91.
[10]延保国.还原型谷胱甘肽联合苦黄注射液治疗慢性乙型肝炎40例疗效观察[J].西部中医药,2012,25(09):68.
 YAN Bao-guo.Curative Observation on Reduced Glutathione for Injection and KuHuang Injection in Treating 40 Cases of Chronic Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2012,25(06):68.
[11]王兰娣,潘文.沙美特罗替卡松联合益气养阴合剂治疗轻症及缓解期COPD36例[J].西部中医药,2012,25(05):76.
 WANG Lan-di,PAN Wen.Treatment for 36 Cases of Chronic Obstructive Pulmonary Disease at Mild and Remission Stages with Salmeterol Fluticasone and Mixture of Replenishing Qi and Nourishing Yin[J].Western Journal of Traditional Chinese Medicine,2012,25(06):76.
[12]许振林,许正龙,贾永兰,等.慢肺饮氧动雾化吸入治疗慢性阻塞性肺疾病137例[J].西部中医药,2013,26(09):5.
 XU Zhenlin,XU Zhenglong,JIA Yonglan,et al.Treatment for 137 Cases of Chronic Obstructive Pulmonary Disease with Oxygen Atomizing Inhalation of ManFei Drink[J].Western Journal of Traditional Chinese Medicine,2013,26(06):5.
[13]李娜,张中新,李双霞.火龙督脉铺灸治疗慢性阻塞性肺疾病稳定期42例[J].西部中医药,2013,26(09):98.
 LI Na,ZHANG Zhongxin,LI Shuangxia.Treating 42 Cases of Chronic Obstructive Pulmonary Disease at Stationary Phase with Fire Dragon Therapy of Long-snake Moxibustion along Governor Meridian[J].Western Journal of Traditional Chinese Medicine,2013,26(06):98.
[14]郑引水,马国义.曲安奈德注射液穴位注射治疗慢性阻塞性肺病急性加重期 35 例[J].西部中医药,2014,27(08):115.
[15]李英梅,刘莉.中医护理对慢性阻塞性肺疾病急性加重期患者的干预效果研究[J].西部中医药,2014,27(10):148.
[16]惠朋利,李英,贺鹏.苏黄止咳胶囊联合噻托溴铵治疗慢性阻塞性肺疾病46例[J].西部中医药,2018,31(12):80.
 HUI Pengli,LI Ying,HE Peng.SuHuang Cough-stopping Capsules and Tiotropium Bromide in Treating 46 Cases of Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(06):80.
[17]尹加亮,童佳兵.中药配方颗粒治疗痰热阻肺型慢性阻塞性肺疾病急性加重期患者的有效性和安全性[J].西部中医药,2021,34(06):89.[doi:10.12174/j.issn.2096-9600.2021.06.21]
 YIN Jialiang,TONG Jiabing.Evaluation of the Safety and Effectiveness of Herbal Granules in the Treatment of Acute Exacerbation of COPD of Phlegm-heat Obstracting Lung Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(06):89.[doi:10.12174/j.issn.2096-9600.2021.06.21]
[18]魏睿,由丽娜,夏杰,等.慢性阻塞性肺疾病中医“寒饮”证患者报告结局量表的信度与效度评价[J].西部中医药,2021,34(02):80.[doi:10.12174/j.issn.2096-9600.2021.02.22]
 WEI Rui,YOU Lina,XIA Jie,et al.Evaluation of Reliability and Validity of CFS-COPD-PRO for COPD patients of "Cold and Fluid" Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(06):80.[doi:10.12174/j.issn.2096-9600.2021.02.22]
[19]刘海,沈娅妮,刘晓梅,等.五禽戏对稳定期慢性阻塞性肺疾病患者有效性的Meta分析[J].西部中医药,2023,36(02):53.[doi:10.12174/j.issn.2096-9600.2023.02.12]
 LIU Hai,SHEN Yani,LIU Xiaomei,et al.Meta Analysis of the Effectiveness of Wu Qin Xi on Stable COPD Patients[J].Western Journal of Traditional Chinese Medicine,2023,36(06):53.[doi:10.12174/j.issn.2096-9600.2023.02.12]
[20]李莉莎,王凤婵.麻杏石甘汤调控TLR4/NF-κB信号通路治疗慢性阻塞性肺疾病的机制[J].西部中医药,2023,36(04):7.[doi:10.12174/j.issn.2096-9600.2023.04.02]
 LI Lisha,WANG Fengchan.The Mechanism of Maxing Shigan Decoction in the Treatment of Chronic Obstructive Pulmonary Disease by Regulating TLR4/NF-κB Signaling Pathway[J].Western Journal of Traditional Chinese Medicine,2023,36(06):7.[doi:10.12174/j.issn.2096-9600.2023.04.02]

备注/Memo

备注/Memo:
收稿日期:2019-08-07*基金项目:国家青年科学基金项目(81600053)。作者简介:陈茜(1975—),女,副主任医师。研究方向:慢阻肺、肺炎、胸腔积液、肺癌的诊治。△通讯作者:李亚(1974—),女,硕士学位,副主任医师。研究方向:慢性阻塞性肺疾病、哮喘、社区获得性肺炎的临床诊治。
更新日期/Last Update: 2020-06-15